GCM
GH icon

Graham Capital Management’s Guardant Health GH Stock Holding History

Graham Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,385
Closed -$652K – 1300
2025
Q4 		$652K Sell
6,385
-2,265
-26% -$203K 0.02% 529
2025
Q3 		$540K Sell
8,650
-8,340
-49% -$454K 0.01% 584
2025
Q2 		$884K Buy
16,990
+10,382
+157% +$464K 0.01% 614
2025
Q1 		$282K Sell
6,608
-6,534
-50% -$282K ﹤0.01% 1018
2024
Q4 		$401K Buy
+13,142
New +$370K 0.01% 818
2024
Q2 		– Sell
-29,804
Closed -$615K – 1152
2024
Q1 		$615K Sell
29,804
-12,345
-29% -$265K 0.01% 570
2023
Q4 		$1.14M Buy
42,149
+7,928
+23% +$208K 0.03% 359
2023
Q3 		$1.01M Buy
34,221
+21,285
+165% +$748K 0.02% 366
2023
Q2 		$463K Sell
12,936
-45,041
-78% -$1.29M 0.01% 577
2023
Q1 		$1.36M Buy
57,977
+11,055
+24% +$316K 0.04% 394
2022
Q4 		$1.28M Buy
+46,922
New +$2.15M 0.04% 444
2022
Q3 		– Sell
-12,717
Closed -$513K – 1147
2022
Q2 		$513K Sell
12,717
-65,644
-84% -$3.25M 0.02% 662
2022
Q1 		$5.19M Buy
78,361
+64,367
+460% +$4.4M 0.18% 61
2021
Q4 		$1.4M Buy
+13,994
New +$1.45M 0.06% 87

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Graham Capital Management's GH Position: Q1 2026 in Review

Graham Capital Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 6,385 shares — an estimated $652K sold.

Graham Capital Management first reported a position in GH in Q4 2021 and held it in 14 quarters. The position peaked at $5.19M in Q1 2022. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Graham Capital Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 6,385 Guardant Health shares in Q1 2026, an estimated $652K.
  • Graham Capital Management first reported a position in Guardant Health in Q4 2021 and held it in 14 quarters.
  • Graham Capital Management's Guardant Health position peaked at $5.19M in Q1 2022.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.